Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2012
06/12/2012CA2214830C Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
06/12/2012CA1341631C Nucleic acid encoding the alpha or beta chains of inhibin and method forsynthesizing polypeptides using such nucleic acid
06/07/2012WO2012075494A1 Novel cyclosporin derivatives for the treatment and prevention of a viral infection
06/07/2012WO2012075490A2 Anti-podoplanin antibodies and methods of use
06/07/2012WO2012075472A2 Chemical entities and therapeutic uses thereof
06/07/2012WO2012075408A1 Chemical and rnai suppressors of neurotoxicity in huntington's disease
06/07/2012WO2012075375A1 Delivery of parathyroid hormones by microinjection systems
06/07/2012WO2012075361A2 In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
06/07/2012WO2012075326A2 Treatment of inflammatory diseases by targeting the adaptor protein ciks
06/07/2012WO2012075244A2 Use of hemoglobin effectors to increase the bioavailability of therapeutic gases
06/07/2012WO2012075243A2 Methods and compositions for targeting sites of neovascular growth
06/07/2012WO2012075241A2 Protease degradable polypeptides and uses thereof
06/07/2012WO2012075173A2 Compositions and method for deimmunization of proteins
06/07/2012WO2012075027A1 Embedded chimeric peptide nucleic acids for generation of induced pluripotent stem cells
06/07/2012WO2012074989A2 Compositions and methods for the treatment of nervous disorders associated with diabetes
06/07/2012WO2012074883A1 Biodegradable drug delivery composition
06/07/2012WO2012074676A2 Glp-1 agonists, dpp-4 inhibitors, compositions, and uses related thereto
06/07/2012WO2012074559A2 Treatment of non-proliferative cystic disease
06/07/2012WO2012074330A2 Fusion peptide comprising dhfas-1 domain and mmp substrate and use thereof for preventing and treating rheumatoid arthritis
06/07/2012WO2012074129A1 Peptide with safer secondary structure, peptide library, and production methods for same
06/07/2012WO2012074120A1 Lissencephaly therapeutic agent
06/07/2012WO2012073459A1 Tomm34 peptides and vaccines including the same
06/07/2012WO2012073111A2 Methods and compositions for monitoring phagocytic activity
06/07/2012WO2012073047A2 Compositions and methods
06/07/2012WO2012072840A1 Use of rgs-14 protein for the prevention and/or treatment of a cognitive disorder and/or a memory disorder
06/07/2012WO2012072815A1 Anticancer fusion protein
06/07/2012WO2012072806A1 Muteins of human lipocalin 2 with affinity for ctla-4
06/07/2012WO2012072777A1 Novel catalases
06/07/2012WO2012072692A2 Use of cytokine-releasing, biodegradable particles in hyaluronic acid for the treatment of cartilage defects, in particular of osteoarthrosis
06/07/2012WO2012072655A1 New treatments of hepatitis c virus infection
06/07/2012WO2012072611A1 SYNTHETIC LIGANDS FOR HUMAN ANTI-Aβ ANTIBODIES
06/07/2012WO2012072082A1 Methods for increasing intracellular activity of hsp70
06/07/2012WO2012072055A1 Use of pacap for treating viral infections in aquatic organisms
06/07/2012WO2012071648A1 Egfr antagonist for the treatment of heart disease
06/07/2012WO2012050874A3 Targeting heme for the treatment of immune mediated inflammatory diseases
06/07/2012WO2012048243A3 Depression disorder therapeutics with creatine analogs
06/07/2012WO2012044783A8 Method of achieving a thymosin beta 4 concentration in a human patient
06/07/2012WO2012037283A3 Admimistration of sns neuroprotective agents to promote hematopoietic regeration
06/07/2012WO2012034197A8 Synthetic gene for expressing sm-14 in pichia pastoris, methods for producing and purifying sm-14 and the use thereof as a vaccine and diagnostic medium
06/07/2012WO2012034132A3 Inhibitors of human ezh2, and methods of use thereof
06/07/2012WO2012031115A3 In vivo anti-tumor activity of a recombinant il-7/hgf(beta) hybrid cytokine and associated methods of use
06/07/2012WO2012024632A3 Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus m2e
06/07/2012WO2012024452A3 Modified relaxin polypeptides and their uses
06/07/2012WO2012019178A9 Methods of treating and diagnosing acute chest syndrome
06/07/2012WO2012018616A3 Polypeptides that bind trail-r1 and trail-r2
06/07/2012WO2011159814A3 Novel live recombinant booster vaccine against tuberculosis
06/07/2012WO2011159071A3 Peptide having antimicrobial or anti-inflammatory activity and pharmaceutical composition containing same as an active ingredient
06/07/2012WO2011152662A3 Ptd-uqcrb fusion polypeptide, and pharmaceutical composition for preventing and treating ischemic diseases, containing same
06/07/2012WO2011073234A9 Dry growth hormone composition transiently linked to a polymer carrier
06/07/2012WO2011003015A8 Nutritional supplement
06/07/2012US20120144504 Caspase-8 and skin disease
06/07/2012US20120143272 Method for treating damaged tissue of the cns
06/07/2012US20120142896 Modified human interferon polypeptides and their uses
06/07/2012US20120142760 Compositions and methods for regulated protein expression in gut
06/07/2012US20120142616 Antineoplastic Hydrogels, and Enzyme-Instructed Preparations Thereof
06/07/2012US20120142615 Methods related to the treatment of neurodegenerative and inflammatory conditions
06/07/2012US20120142614 Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis
06/07/2012US20120142613 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
06/07/2012US20120142612 Cytokine protein family
06/07/2012US20120142611 Repeat protein from collection of repeat proteins comprising repeat modules
06/07/2012US20120142610 Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap
06/07/2012US20120142609 Non human animal models for increased retinal vascular permeability
06/07/2012US20120142608 Rca locus analysis to assess susceptibility to amd and mpgnii
06/07/2012US20120142607 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
06/07/2012US20120142606 Tumor targeting peptides, therapeutic and diagnostic compositions compressing the peptides
06/07/2012US20120142605 Methods of treating psoriasis
06/07/2012US20120142604 Novel applications of hip/pap or derivatives thereof
06/07/2012US20120142603 Bioadhesive patch for sutureless closure of soft tissue
06/07/2012US20120142602 Composition and Method for Preventing or Treating a Tauopathy
06/07/2012US20120142601 Modified Peptides and Uses Thereof
06/07/2012US20120142600 Analogs of ShK Toxin and their Uses in Selective Inhibition of Kv1.3 Potassium Channels
06/07/2012US20120142598 Edible compositions for preventing hair loss
06/07/2012US20120142597 Biomolecular coating for implants
06/07/2012US20120142596 Agent for stimulating mobilization of endothelial progenitor cells
06/07/2012US20120142595 Tissue protective peptides and uses thereof
06/07/2012US20120142593 Factor VIII Variants and Methods of Use
06/07/2012US20120142592 Nasal calcitonin formulations containing chlorobutanol
06/07/2012US20120142591 Method of treating intraoccular tissue pathologies with nerve growth factor
06/07/2012US20120142590 Methods and Compounds Regulating the Erythroid Response to Iron Deficiency
06/07/2012US20120142589 Tissue-protective cytokines for the protection, restoration and enhancement of responsive cells, tissues and organs
06/07/2012US20120142588 Hsp therapy in conjunction with a low antigenicity diet
06/07/2012US20120142587 Liquid enteral nutritional composition with a low monovalent metal ion content
06/07/2012US20120142586 Treatment for obesity
06/07/2012US20120142585 Leptin antagonist and methods of use
06/07/2012US20120142584 Novel transporter constructs and transporter cargo conjugate molecules
06/07/2012US20120142583 Methods of inhibiting and treating bacterial biofilms by metal chelators
06/07/2012US20120142582 Combination of Dopamine Agonists Plus First Phase Secretagogues for the Treatment of Metabolic Disorders
06/07/2012US20120142581 Polymer Formulations for Delivery of Bioactive Materials
06/07/2012US20120142580 Opioid receptors stimulating compounds (thymoquinone, nigella sativa) and food allergy
06/07/2012US20120142099 Novel bak binding protein, dna encoding the protein, and methods of use thereof
06/07/2012US20120142071 Thymidine Kinase Mutants
06/07/2012US20120141611 Methods and compositions using ergothioneine to treat a variety of health related factors
06/07/2012US20120141608 Systemic administration of nac as an adjunct in the treatment of bioterror exposures such as anthrax, virus or radiation and use in combination with dhea for the treatment of viruses
06/07/2012US20120141605 Pyrazoloanthrone and derivatives thereof for treatment of cancer and excess androgen states
06/07/2012US20120141594 Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy, and anti-cancer activity and methods of use
06/07/2012US20120141590 Technology for the Preparation of Microparticles
06/07/2012US20120141575 Collagen For Use In The Treatment Of Skin Diseases
06/07/2012US20120141560 Tumor and infectious disease therapeutic compositions
06/07/2012US20120141558 Alginate-based nanofibers and related scaffolds
06/07/2012US20120141557 Highly-mineralized osteogenic sponge compositions and uses thereof
1 ... 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 ... 3163